Literature DB >> 8618308

Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease.

V Menéndez1, F Cofán, R Talbot-Wright, M J Ricart, R Gutiérrez, P Carretero.   

Abstract

PURPOSE: We evaluated the urodynamic changes produced by insulin-dependent diabetes mellitus with end stage renal disease.
MATERIALS AND METHODS: A urodynamic evaluation was performed on 51 young patients (mean age plus or minus standard deviation 35 +/- 6 years) with long-term diabetes mellitus (average 21 +/- 6 years) and end stage renal disease (86% on dialysis).
RESULTS: The urodynamic study was abnormal in 84% of the patients. The bladder was hypersensitive in 39% and hyposensitive in 30% of the cases, and maximum vesical capacity was greater than 600 ml. in 33%. An acontractile detrusor was noted in 6% of the patients, while 4% had detrusor hyperreflexia and 35% had bladder outlet obstruction.
CONCLUSIONS: A high frequency of vesical alterations was observed, which were modified by association of progressive vesical dysfunction and diabetes mellitus. In diabetes mellitus dialysis protects against detrusor hypocontractility but predisposes the patients to have bladder obstruction.

Entities:  

Mesh:

Year:  1996        PMID: 8618308

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Relationship between neck circumference and overactive bladder in women with metabolic syndrome: a preliminary study.

Authors:  Yigit Akin; Hakan Gulmez; Murat Savas; Serdar Aykan; Ozde Onder; Selcuk Yucel
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

2.  Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.

Authors:  Aruna V Sarma; Jennifer L St Sauver; John M Hollingsworth; Debra J Jacobson; Michaela E McGree; Rodney L Dunn; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2011-11-23       Impact factor: 2.649

3.  Bladder dysfunction in children and adolescents after renal transplantation.

Authors:  Maria Herthelius; Helena Oborn
Journal:  Pediatr Nephrol       Date:  2006-03-25       Impact factor: 3.714

4.  Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases.

Authors:  Jason D Hipp; Kelvin P Davies; Moses Tar; Mira Valcic; Abraham Knoll; Arnold Melman; George J Christ
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

5.  Incidence, predictors, and associated outcomes of prostatism after kidney transplantation.

Authors:  Frank P Hurst; Robert T Neff; Edward M Falta; Rahul M Jindal; Krista L Lentine; John S Swanson; Lawrence Y Agodoa; Kevin C Abbott
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

6.  Survey on the perception of urogenital complications in diabetic patients.

Authors:  Jong Wook Kim; Ji Yun Chae; Jin Wook Kim; Cheol Yong Yoon; Mi Mi Oh; Je Jong Kim; Du Geon Moon
Journal:  World J Mens Health       Date:  2012-12-27       Impact factor: 5.400

7.  Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; George J Christ; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2008-03-12       Impact factor: 5.911

8.  Experimental study of excitability and autorhthmicity in urinary bladder detrusor of diabetes rats.

Authors:  Dongwen Wang; Weibing Shuang; Jingyu Wang; Zhangqun Ye; Bowei Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 9.  Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia.

Authors:  T A Boon; G E Van Venrooij; M D Eckhardt
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 3.092

10.  Bladder dysfunction and end stage renal disease.

Authors:  Dirk-Henrik Zermann; Uwe Löffler; Olaf Reichelt; Heiko Wunderlich; Steffen Wilhelm; Jörg Schubert
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.